Skip to main content
Clinical Trials/IRCT20200718048129N1
IRCT20200718048129N1
Recruiting
Phase 3

Evaluation and comparison of the effectiveness of Hydroxychloroquin versus Clarithromycin in recovery of dyspnea and Caugh at the end of the acute phase of COVID-19 treatment

Iran University of Medical Sciences0 sites45 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
45
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with definitive diagnosis of COVID19 were hospitalized and treated
  • Patients with COVID19 who still have dyspena and cough two weeks after discharge from the hospital
  • Patients with COVID19 who continue to have lung involvement on CT SCAN two weeks after discharge

Exclusion Criteria

  • Patients with comorbidities such as chronic heart or lung disease before COVID19
  • The need for long\-term use of drugs that have an irreversible interaction with the drugs used in the plan.

Outcomes

Primary Outcomes

Not specified

Similar Trials